儿童鼻部手术中羟甲唑啉使用的血流动力学与药代动力学分析
前瞻性试验纳入27例2至17岁接受鼻部手术的儿童,按常规临床实践放置羟甲唑啉浸泡棉片(1.5 mL 0.05%溶液),在5至150分钟采血检测并记录血流动力学。结果显示棉片相对生物利用度为喷雾制剂的2.3倍(95%CI 1.6-3.2),吸收半衰期64分钟(95%CI 44-90),在观察到的血清浓度0.04-7.6 μg/L下平均动脉压未升高,血流动力学变化临床可忽略。
要点
- 棉片给药的相对生物利用度为喷雾制剂的2.3倍(95%CI 1.6-3.2)。
- 黏膜吸收缓慢,吸收半衰期64分钟(95%CI 44-90)。
- 血清浓度0.04-7.6 μg/L下平均动脉压未升高,血流动力学变化临床可忽略。
核心结论
- 尽管对黏膜给予羟甲唑啉存在顾虑,本研究发现按常规临床使用羟甲唑啉浸泡棉片时血流动力学变化临床可忽略。
- 与喷雾制剂数据相比,棉片的生物利用度增加两倍,但全身吸收非常缓慢,导致血清浓度低、血流动力学影响有限。
研究设计与样本
- 前瞻性试验,纳入27例2至17岁接受功能性内镜鼻窦手术、鼻甲切除或腺样体切除术的儿童。
- 由外科医生按本研究中心常规临床实践放置羟甲唑啉浸泡棉片(1.5 mL 0.05%溶液)。
- 于5、10、20、45、90和150分钟采血检测羟甲唑啉,每5分钟记录血流动力学数据,采用混合效应回归及群体药代动力学/药效学建模分析。
主要发现
- 27例患者年龄7±4岁,接受2至12块棉片(3-18 mL)羟甲唑啉。
- 相对于喷雾制剂的生物利用度为2.3(95%CI 1.6-3.2),黏膜表面吸收缓慢,吸收半衰期64分钟(95%CI 44-90)。
- 在观察到的羟甲唑啉血清浓度0.04-7.6 μg/L下,平均动脉压未随羟甲唑啉滴入而升高。
临床怎么用
- 本研究中心按常规临床实践放置羟甲唑啉浸泡棉片(1.5 mL 0.05%溶液)。
- 作者认为,按常规临床使用羟甲唑啉浸泡棉片时血流动力学变化临床可忽略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Oxymetazoline is an α-adrenergic agonist that is commonly used as a topical hemostatic agent in the operating room during ear, nose, and throat surgery. There are limited data on oxymetazoline pharmacokinetics in children who undergo general anesthesia. We assessed the hemodynamic effects and systemic absorption of topically applied oxymetazoline in children undergoing various nasal procedures. STUDY DESIGN: Prospective trial. METHODS: Children ages 2 to 17 years undergoing functional endoscopic sinus surgery, turbinate resection, or adenoidectomy were enrolled. The surgeon placed oxymetazoline-soaked pledgets (1.5 mL of 0.05% solution) according to our usual clinical practice. Blood samples for oxymetazoline assay were drawn at 5, 10, 20, 45, 90, and 150 minutes, and hemodynamic data were recorded at 5-minute intervals. Data analysis included mixed-effects regression and population pharmacokinetic/pharmacodynamic modeling. RESULTS: The analysis included 27 patients, age 7 ± 4 years, who received between 2 and 12 pledgets (3-18 mL) of oxymetazoline. Relative bioavailability compared to the spray formulation was 2.3 (95% confidence interval [CI]: 1.6-3.2), with slow absorption from the mucosal surface (absorption half-life 64 minutes; 95% CI: 44-90). Mean arterial pressure did not increase with oxymetazoline instillation at the observed oxymetazoline serum concentrations (0.04-7.6 μg/L). CONCLUSIONS: Despite concerns regarding oxymetazoline administration to mucosal membranes, we found that hemodynamic changes were clinically negligible with our usual clinical use of pledgets soaked in oxymetazoline. Compared to data on oxymetazoline in spray formulation, bioavailability was increased twofold with pledgets, but systemic absorption was very slow, contributing to low serum concentrations and limited hemodynamic effects. LEVEL OF EVIDENCE: 1b. Laryngoscope, 129:2775-2781, 2019.
引用
- Cartabuke RS, Anderson BJ, Elmaraghy C, et al. Hemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in children. Laryngoscope. 2019. PMID: 30786035. doi:10.1002/lary.27760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。